Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
$BTC: Researchers at the University of New Mexico in Albuquerque Have a Beef With Bitcoin
-
$BTC: A Weaker U.S. Dollar Allows Bitcoin and Rest of the Crypto Market to Move Higher
-
Cryptos Slide After A Brilliant Rally
-
GrafTech Plunges 16% On Lower Quarterly Profit, Outlook
-
Bloomberg Strategist: Ethereum Is ‘Doing to the World What Netflix Did to Blockbuster’